ScinoPharm receives US FDA approval for glatiramer acetate injection to treat multiple sclerosis: Taiwan Tuesday, January 6, 2026, 14:00 Hrs [IST] ScinoPharm Taiwan, a professiona ...
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch ...
The global Pharmaceutical Isolator market was valued at USD 432 Million in the year 2024 and is projected to reach a revised size of USD 509 Million by 2031, growing at a CAGR of 2.4% during the ...
In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...
ProMed, a leading contract manufacturer specializing in medical-grade silicone and plastic components, provides comprehensive support for medical device, pharmaceutical, and combination drug-device ...
The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...
The new Emerson DeltaV PKM library reportedly cuts months from drug development by providing pre-built specification elements ...
Ipsen gains exclusive global rights, outside of Greater China, for development, manufacturing and commercialization of SIM0613, a ...
Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the pharmaceutical industry's impact on healthcare.
President Donald Trump on Friday, Dec. 19, announced nine pharmaceutical companies have agreed to sell medications at lower prices, part of his administration's effort to lower drug prices to levels ...
Well, good morning, everyone. Thank you for joining us for the year-end review and corporate update of Avicanna Inc. It's a pleasure to be hosting you this year. Giving you an update on another very ...